Back to Search Start Over

Prescription Medications Alter Neuronal and Glial Cholesterol Synthesis.

Authors :
Tallman KA
Allen LB
Klingelsmith KB
Anderson A
Genaro-Mattos TC
Mirnics K
Porter NA
Korade Z
Source :
ACS chemical neuroscience [ACS Chem Neurosci] 2021 Feb 17; Vol. 12 (4), pp. 735-745. Date of Electronic Publication: 2021 Feb 02.
Publication Year :
2021

Abstract

Mouse brain contains over 100 million neuronal, glial, and other support cells. Developing neurons and astrocytes synthesize their own cholesterol, and disruption of this process can occur by both genetic and chemical mechanisms. In this study we have exposed cultured murine neurons and astrocytes to six different prescription medications that cross the placenta and blood-brain barriers and analyzed the effects of these drugs on cholesterol biosynthesis by an LC-MS/MS protocol that assays 14 sterols and 7 oxysterols in a single run. Three antipsychotics (haloperidol, cariprazine, aripiprazole), two antidepressants (trazodone and sertraline), and an antiarhythmic (amiodarone) inhibited one or more sterol synthesis enzymes. The result of the exposures was a dose-dependent increase in levels of various sterol intermediates and a decreased level of cholesterol in the cultured cells. Four prescription medications (haloperidol, aripiprazole, cariprazine, and trazodone) acted primarily on the DHCR7 enzyme. The result of this exposure was an increase in 7-dehydrocholesterol in neurons and astrocytes to levels that were comparable to those found in cultured neurons and astrocytes from transgenic mice that carried a Dhcr7 pathogenic mutation modeling the neurodevelopmental disorder Smith-Lemli-Opitz syndrome.

Details

Language :
English
ISSN :
1948-7193
Volume :
12
Issue :
4
Database :
MEDLINE
Journal :
ACS chemical neuroscience
Publication Type :
Academic Journal
Accession number :
33528983
Full Text :
https://doi.org/10.1021/acschemneuro.0c00765